← 返回

患者与家庭照护者在 CAR-T 细胞治疗后的体验:一项定性研究

英文原题:Experiences of Patients and Family Caregivers After Chimeric Antigen Receptor T-Cell Therapy: A Qualitative Study.

查看英文原题

Experiences of Patients and Family Caregivers After Chimeric Antigen Receptor T-Cell Therapy: A Qualitative Study.

PubMed 2025/10/01(内容时间) Semin Oncol Nurs Q1 · IF 3.2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

患者需要在治疗前、治疗中和治疗后获得个体化咨询。

中文摘要

探讨CAR-T 细胞治疗后复发/难治性B细胞淋巴瘤患者及其家庭照护者的体验和咨询需求。

采用质性描述性设计。2021年12月至2022年3月,分别对患者或患者与其家庭照护者共同开展12次访谈。访谈内容逐字转录、编码并进行质性主题分析。

研究确定了影响CAR-T 治疗后体验和咨询需求的五个主题:(1)情绪影响;(2)对日常生活的影响;(3)个体应对策略;(4)社会支持;(5)专业照护。多数患者担心疾病进展和感染。部分患者认为,与既往“化疗后再接受自体干细胞移植”的治疗相比,CAR-T 疗法更容易耐受。患者及照护者均强调支持系统和清晰治疗信息的重要性。部分照护者认为治疗历程比患者本人更具挑战性,尤其是在发生神经系统副作用时。

患者在治疗前、治疗中和治疗后均需要个体化咨询。本研究识别了治疗期间及后续照护应考虑的重要主题,其中护士发挥关键作用。家庭照护者十分重要,但其治疗体验可能与患者不同,因此也可能需要不同的咨询支持。及早识别个体应对策略可作为改进照护的起点。护理实践意义:CAR-T 治疗流程复杂,毒性特征独特;家庭照护者发挥重要作用。患者和照护者都可能在情绪健康、日常生活和社会功能方面受到影响。血液科护士应了解CAR-T 治疗可能带来的影响,认识到每个人的应对策略不同,并据此提供个体化咨询。

展开英文摘要原文

This study aimed to explore the experiences and counseling needs of family caregivers and patients with relapsed or refractory B-cell lymphoma after CAR T-cell therapy.

A qualitative descriptive design was used. Twelve interviews were conducted with patients individually or together with their family caregiver between December 2021 and March 2022. The interviews were transcribed verbatim, coded and a qualitative thematic analysis was carried out.

Five themes that influenced experiences and counseling needs after CAR T-cell therapy were identified: (1) emotional impact, (2) impact on daily life, (3) individual coping strategies, (4) social support, and (5) professional care. Most patients experienced fear of disease progression and infections. Others experienced CAR T-cell therapy as easier than previous treatment with chemotherapy followed by an autologous stem cell transplant. Both patients and family caregivers emphasized the importance of their support system and clear information about the treatment. Some family caregivers found the treatment pathway more challenging than patients, especially when neurological side-effects occurred.

Patients need personalized counseling before, during, and after treatment. Our study helps to identify important themes to consider during (after)care, where nurses play a crucial role. Family caregivers are important and may experience treatment differently. Therefore, they may need different counseling. Early identification of personal coping strategies can be a starting point for improving care. IMPLICATIONS FOR NURSING PRACTICE: CAR T-cell therapy can be a complex pathway and has a unique profile of toxicity. Family caregivers play an important role. Both can experience an impact on emotional well-being, daily life and social functioning. Hematology nurses should be aware of the potential impact of CAR T-cell therapy with the consideration that every person has different coping strategies and keep in mind that each person has different coping strategies and may need different counseling.

论文信息

作者
Snoek B、Oldenmenger WH、van Hooft SM、Mutsaers PGNJ
单位
Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Oncology, Rotterdam, the Netherlands. Electronic address: b.snoek@erasmusmc.nl.Netherlands
文献类型
非美国政府资助研究
期刊
Seminars in oncology nursing2025 Oct
原文标识
PubMed 41077473 · DOI 10.1016/j.soncn.2025.151951